Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...

Novo Nordisk's Victoza (liraglutide) has become the only approved diabetes drug in the GLP-1 agonist class shown to demonstrate a cardiac safety benefit, although it faces competition from a ...

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

Victoza is one of five new generation diabetes medicines that are in short supply Diabetes patients have told the BBC they are struggling without what they have called a "wonder drug". Experts ...

Victoza (liraglutide) shares its main ingredient with Saxenda and is an injectable GLP-1 agonist. Unlike Saxenda, Victoza has only been FDA-approved for treating diabetes thus far. Contrave ...

Are you using, or planning to use the offical UN Sustainable Development Goals (SDGs) logo, including the colour wheel and 17 icons in your communications materials? Did you know that the SDG ...

Lexaria Bioscience (LEXX) received partial 12-week blood sugar results from the recently completed animal study WEIGHT-A24-1. The company said, ...

Lexaria Bioscience (LEXX) has received partial 12-week body weight results from the recently completed animal study WEIGHT-A24-1. Lexaria is ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...